VivaVision Biotech, Inc   Report issue

For profit Phase 2
Founded: Shanghai China (2016)

Organization Overview

First Clinical Trial
2020
NCT04556838
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

VivaVision Biotech, Inc